These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8196175

  • 1. [Thyroxine-binding proteins--familial euthyroid hyperthyroxinemia due to point mutations of transthyretin].
    Hishinuma A, Mochizuki Y, Kasai K, Shimoda S.
    Nihon Rinsho; 1994 Apr; 52(4):886-9. PubMed ID: 8196175
    [Abstract] [Full Text] [Related]

  • 2. A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
    Refetoff S, Marinov VS, Tunca H, Byrne MM, Sunthornthepvarakul T, Weiss RE.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3335-40. PubMed ID: 8784093
    [Abstract] [Full Text] [Related]

  • 3. Thyroxine interactions with transthyretin: a comparison of 10 different naturally occurring human transthyretin variants.
    Rosen HN, Moses AC, Murrell JR, Liepnieks JJ, Benson MD.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):370-4. PubMed ID: 8345041
    [Abstract] [Full Text] [Related]

  • 4. A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia.
    Moses AC, Rosen HN, Moller DE, Tsuzaki S, Haddow JE, Lawlor J, Liepnieks JJ, Nichols WC, Benson MD.
    J Clin Invest; 1990 Dec; 86(6):2025-33. PubMed ID: 1979335
    [Abstract] [Full Text] [Related]

  • 5. Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves disease.
    Cameron SJ, Hagedorn JC, Sokoll LJ, Caturegli P, Ladenson PW.
    Clin Chem; 2005 Jun; 51(6):1065-9. PubMed ID: 15833783
    [Abstract] [Full Text] [Related]

  • 6. Thyroxine binding in a TTR Met 119 kindred.
    Alves IL, Divino CM, Schussler GC, Altland K, Almeida MR, Palha JA, Coelho T, Costa PP, Saraiva MJ.
    J Clin Endocrinol Metab; 1993 Aug; 77(2):484-8. PubMed ID: 8102146
    [Abstract] [Full Text] [Related]

  • 7. Etiology and outcome of non-estrogen associated hyperthyroxinemia in euthyroid patients at the San Juan City Hospital.
    Alegre M, Meléndez EG, Colón G.
    Bol Asoc Med P R; 1996 Aug; 88(1-3):12-5. PubMed ID: 8885441
    [Abstract] [Full Text] [Related]

  • 8. Transthyretin mutations in hyperthyroxinemia and amyloid diseases.
    Saraiva MJ.
    Hum Mutat; 2001 Jun; 17(6):493-503. PubMed ID: 11385707
    [Abstract] [Full Text] [Related]

  • 9. Novel mutation p.A64D in the Serpina7 gene as a cause of partial thyroxine-binding globulin deficiency associated with increases affinity in transthyretin by a known p.A109T mutation in the TTR gene.
    Sklate RT, Olcese MC, Maccallini GC, Sarmiento RG, Targovnik HM, Rivolta CM.
    Horm Metab Res; 2014 Feb; 46(2):100-8. PubMed ID: 24356794
    [Abstract] [Full Text] [Related]

  • 10. Production and functional analysis of normal and variant recombinant human transthyretin proteins.
    Murrell JR, Schoner RG, Liepnieks JJ, Rosen HN, Moses AC, Benson MD.
    J Biol Chem; 1992 Aug 15; 267(23):16595-600. PubMed ID: 1644839
    [Abstract] [Full Text] [Related]

  • 11. Hyperthyroxinemia due to the coexistence of two raised affinity thyroxine-binding proteins (albumin and prealbumin) in one family.
    Lalloz MR, Byfield PG, Goel KM, Loudon MM, Thomson JA, Himsworth RL.
    J Clin Endocrinol Metab; 1987 Feb 15; 64(2):346-52. PubMed ID: 3098776
    [Abstract] [Full Text] [Related]

  • 12. Elevated thyroxine levels in a euthyroid patient. A search for the cause of euthyroid hyperthyroxinemia.
    Uy HL, Reasner CA.
    Postgrad Med; 1994 Oct 15; 96(5):195-202. PubMed ID: 7937417
    [Abstract] [Full Text] [Related]

  • 13. Threonine for alanine substitution at position 109 of transthyretin differentially alters human transthyretin's affinity for iodothyronines.
    Rosen HN, Murrell JR, Liepnieks JJ, Benson MD, Cody V, Moses AC.
    Endocrinology; 1994 Jan 15; 134(1):27-34. PubMed ID: 8275943
    [Abstract] [Full Text] [Related]

  • 14. Transient prealbumin-associated hyperthyroxinemia in TSH-producing pituitary adenoma.
    Lind P, Langsteger W, Költringer P, Wakonig P, Eber B, Mokry M, Beham A, Eber O.
    Nuklearmedizin; 1990 Feb 15; 29(1):40-3. PubMed ID: 2108434
    [Abstract] [Full Text] [Related]

  • 15. Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine-binding prealbumin.
    Moses AC, Lawlor J, Haddow J, Jackson IM.
    N Engl J Med; 1982 Apr 22; 306(16):966-9. PubMed ID: 6801514
    [No Abstract] [Full Text] [Related]

  • 16. Specific methods to identify plasma binding abnormalities in euthyroid hyperthyroxinemia.
    Stockigt JR, Dyer SA, Mohr VS, White EL, Barlow JW.
    J Clin Endocrinol Metab; 1986 Jan 22; 62(1):230-3. PubMed ID: 3079602
    [Abstract] [Full Text] [Related]

  • 17. Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.
    Almeida MR, Damas AM, Lans MC, Brouwer A, Saraiva MJ.
    Endocrine; 1997 Jun 22; 6(3):309-15. PubMed ID: 9368688
    [Abstract] [Full Text] [Related]

  • 18. Thyroxine binding by human transthyretin variants: mutations at position 119, but not position 54, increase thyroxine binding affinity.
    Curtis AJ, Scrimshaw BJ, Topliss DJ, Stockigt JR, George PM, Barlow JW.
    J Clin Endocrinol Metab; 1994 Feb 22; 78(2):459-62. PubMed ID: 7906282
    [Abstract] [Full Text] [Related]

  • 19. Change in structure of the N-terminal region of transthyretin produces change in affinity of transthyretin to T4 and T3.
    Prapunpoj P, Leelawatwatana L, Schreiber G, Richardson SJ.
    FEBS J; 2006 Sep 22; 273(17):4013-23. PubMed ID: 16879610
    [Abstract] [Full Text] [Related]

  • 20. Elevated thyroxine and free thyroxine in euthyroid patients: familial dysalbuminemic hyperthyroxinemia.
    Haas S.
    S D J Med; 1990 Mar 22; 43(3):5-7. PubMed ID: 2109350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.